MaxCyte Signs Clinical and Commercial License with Sana Biotechnology ...Middle East

GAITHERSBURG, Md., Aug. 9, 2021 /PRNewswire/ -- MaxCyte, Inc. (Nasdaq: MXCT) (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the signing of a clinical and commercial license with Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on...

Hence then, the article about maxcyte signs clinical and commercial license with sana biotechnology was published today ( Monday 09/08/2021 - 09:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MaxCyte Signs Clinical and Commercial License with Sana Biotechnology )

Also on site :

• Snap says its $400M deal with Perplexity ‘amicably ended’
• Meghan Markle celebrates Prince Archie’s 7th birthday with never-before-seen photos: ‘Sweet boy’
• ‘Destroyed his baby’: Trump takes aim at CNN after founder’s death